CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
LIG Biowise Ltd is creating a rapid diagnostic system to help healthcare professionals quickly distinguish between viral and bacterial infections. This innovation aims to reduce unnecessary antibiotic prescriptions and combat antibiotic resistance, ultimately improving patient care and reducing healthcare costs.
LIG Biowise Ltd specialises in the development of targeted nanodrugs and targeted nanodiagnostic systems.
The company is now developing a next generation rapid diagnostic system for use by healthcare staff to quickly determine whether medical symptoms are a viral infection or bacterial infection.
Many infectious diseases present with similar symptoms and it can be difficult to correctly diagnose and treat a patient without further diagnostic investigation.
Infectious diseases are one of the majo…
LIG BIOWISE LIMITED
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
